No ratings yet
Taught by or worked with Shusen? Your rating helps other students choose.
Shusen Wang serves as a doctoral supervisor at the School of Medicine of Nankai University. He is also Chief Physician at the Organ Transplant Center of Tianjin First Central Hospital. His research centers on transplantation medicine, with a focus on stem cell-derived islet transplantation for the treatment of Type 1 diabetes. In 2024, Wang co-authored a study published in the journal Cell detailing the transplantation of chemically induced pluripotent stem-cell-derived islets, which demonstrated potential for treating Type 1 diabetes. Additional research contributions include work on vascularized multi-organoid models and related studies in organ transplantation and stem cell applications. Wang has collaborated with researchers from Nankai University and affiliated institutions on projects involving preclinical and clinical investigations in transplant medicine.
Wang has held appointments including roles at the Research Institute of Transplant Medicine and NHC Key Laboratory for Critical Care Medicine. His professional activities encompass leadership in collaborative research teams and contributions to publications on topics such as mesenchymal stem cells and islet pathophysiology. Public records confirm his affiliation with Nankai University’s School of Medicine and the Tianjin First Central Hospital Organ Transplant Center.
Explore China's stem cell breakthroughs at Naval Medical University and Nankai University restoring insulin in diabetes patients. Detailed cases, methods, and higher ed impacts.
Photo by Antoine Dautry on Unsplash
Photo by Chris Liverani on Unsplash
Photo by Peter Burdon on Unsplash
Photo by Andrii Zhuk on Unsplash
Photo by EESOFUFFZICH on Unsplash
Photo by Google DeepMind on Unsplash
Photo by Gabriele Malaspina on Unsplash
